Open-Label Extension Trial to Characterize the Long-term Safety and Tolerability of Elamipretide in Subjects With Genetically Confirmed Primary Mitochondrial Myopathy (PMM)
Clinical trial NCT02976038 · TERMINATED
Trial details
- NCT number
- NCT02976038
- Sponsor
- Stealth BioTherapeutics Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-01
- Primary completion
- 2020-03-09
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.